The Effect of bılateral Erector spına Plan Block on postoperatıve paın ın spınal Surgery
ESPB
The Effect of Bilateral Erector Spina Plan Block Performed After Lumbar Spinal Stabilization Surgery on Postoperative Patient Recovery and Pain
1 other identifier
interventional
50
1 country
1
Brief Summary
Patients undergoing lumbar spinal stabilization surgery may experience severe postoperative pain lasting at least three days. Analgesia after lumbar stabilization surgery is beneficial for early recovery and is therefore necessary. However, traditional opioid-based analgesic techniques are associated with many undesirable effects, including nausea, vomiting, itching, and sedation. Inadequate postoperative pain control also has numerous adverse effects on physiological systems such as the cardiovascular, pulmonary, gastrointestinal, immunological, renal, and hematological systems. Furthermore, inadequate postoperative pain control increases hospital stay, mortality and morbidity, prolongs patient ambulation time, increases patient costs, reduces patient satisfaction, and can lead to chronic postoperative pain. Nonsteroidal anti-inflammatory drugs (NSAIDs), opioid analgesics, and local anesthetics are frequently preferred options for providing postoperative analgesia. In cases where these agents are insufficient to prevent pain, regional techniques are often preferred to reduce the need for opioids. Erector spina plane block (ESPB), a component of multimodal analgesia and one of the regional techniques, was first used by Forero et al. for analgesic purposes in thoracic neuropathic pain and subsequently gained popularity. While ESPB is frequently performed at the thoracic level, its use continues to increase today.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 6, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedApril 17, 2026
April 1, 2026
7 months
April 6, 2026
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
POSTOPERATIVE PAIN SCORES
Pain will be assessed using the Numerical rating scale (NRS) score at postoperatively.
The Numerical rating scale (NRS) score will be applied at 0, 2, 4, 6, 12, and 24 hours postoperatively.Numerical rating scale (NRS), 0 to 10. Zero indicates the absence of pain, while ten indicates severe pain.
Secondary Outcomes (1)
Evaluation of postoperative analgesic consumption and hospital stay duration.
Postoperative 24-hour period
Study Arms (1)
ESPB GROUP
EXPERIMENTALUnder ultrasound guidance, bilateral erector spinae plane block will be performed on the ESPB group one level above the appropriate area for pediatric tethered cord surgery using the anesthetic drug bupivacaine.
Interventions
In the ESP Block group, with the patient in the prone position, the research anesthesia team will insert a block needle through the skin one level above the surgical level using a linear probe guided by USG. The needle will pass through the trapezius and erector spinae muscles, and upon reaching the transverse process (approximately 2-3 cm deep), a test dose of 0.5-1 mL of 0.9% NaCl will be applied between the erector spinae fascia and the vertebral transverse process to confirm needle placement. After confirmation of fascial opening, a local anesthetic volume of 2 mL per vertebral pressure will be calculated, not exceeding a maximum dose of 2 mg/kg of 0.5% bupivacaine. This total volume will be diluted by half with 0.9% NaCl solution to prepare a 0.25% bupivacaine concentration. The calculated local anesthetic solution will be applied to the erector spinae region for ESPB. The same procedures will be performed on the opposite side.
For the ESP Block group, under USG guidance with the patient in prone position, a linear probe will be placed in the parasagittal plane one level above the operative level, and after visualizing the transverse process with an in-plane approach, a 50 mm long block needle will be inserted through the skin. A test dose of 0.5-1 mL of 0.9% NaCl will be administered between the erector spinae fascia and the transverse process of the vertebra to confirm needle placement. After confirming that the fascia has opened, a local anesthetic volume of 2 mL per vertebral pressure will be calculated, not exceeding a maximum dose of 2 mg/kg of 0.5% bupivacaine. This total volume will be diluted halfway with 0.9% NaCl solution to prepare a 0.25% bupivacaine concentration. The calculated local anesthetic solution will be administered to the erector spinae area, and ESPB will be performed. The same procedures will be performed on the opposite side.
Eligibility Criteria
You may qualify if:
- Patients who volunteer to participate in the study
- Patients aged 18-65 years
- Patients with ASA (American Society of Anesthesiologists) physical status I, II, and III
- Patients who will undergo elective lumbar stabilization surgery
You may not qualify if:
- Patients who do not consent to participate in the study
- Patients with ASA physical status IV and V
- Patients using anticoagulant medications
- Patients with allergy to local anesthetic drugs
- Patients undergoing lumbar stabilization surgery at level three or higher
- Patients with a history of gastrointestinal bleeding
- Patients with a history of psychiatric illness (Major Depression, Schizophrenia, Bipolar Affective Disorder)
- Patients with narcotic drug and/or alcohol dependence
- Patients with a history of central and/or peripheral neurological disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bursa yüksek ihtisas eğitim ve araştırma hastanesi BURSA, Bursa, Türkiye, BURSA, Bursa 16310
Bursa, Bursa, 16310, Turkey (Türkiye)
Related Publications (1)
Stewart JW, Dickson D, Van Hal M, Aryeetey L, Sunna M, Schulz C, Alexander JC, Gasanova I, Joshi GP. Ultrasound-guided erector spinae plane blocks for pain management after open lumbar laminectomy. Eur Spine J. 2024 Mar;33(3):949-955. doi: 10.1007/s00586-023-07881-4. Epub 2023 Aug 12.
PMID: 37572144RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ASSOCIATE PROFESSOR
Study Record Dates
First Submitted
April 6, 2026
First Posted
April 17, 2026
Study Start
September 1, 2024
Primary Completion
April 1, 2025
Study Completion
May 1, 2025
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
The study protocol and results can be shared.